Free Trial

Becton, Dickinson and Company (BDX) Competitors

Becton, Dickinson and Company logo
$179.02 +0.75 (+0.42%)
As of 01:21 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BDX vs. COO, HOLX, HSIC, AMN, CAH, DVA, MCK, TMO, ISRG, and BSX

Should you be buying Becton, Dickinson and Company stock or one of its competitors? The main competitors of Becton, Dickinson and Company include Cooper Companies (COO), Hologic (HOLX), Henry Schein (HSIC), AMN Healthcare Services (AMN), Cardinal Health (CAH), DaVita (DVA), McKesson (MCK), Thermo Fisher Scientific (TMO), Intuitive Surgical (ISRG), and Boston Scientific (BSX). These companies are all part of the "medical" sector.

Becton, Dickinson and Company vs. Its Competitors

Becton, Dickinson and Company (NYSE:BDX) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

Becton, Dickinson and Company has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.

Cooper Companies has a net margin of 10.39% compared to Becton, Dickinson and Company's net margin of 7.28%. Becton, Dickinson and Company's return on equity of 15.99% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company7.28% 15.99% 7.36%
Cooper Companies 10.39%9.60%6.35%

Becton, Dickinson and Company has higher revenue and earnings than Cooper Companies. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$20.18B2.53$1.71B$5.2434.03
Cooper Companies$3.90B3.73$392.30M$2.0635.27

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Comparatively, 2.0% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Becton, Dickinson and Company currently has a consensus target price of $219.22, suggesting a potential upside of 22.94%. Cooper Companies has a consensus target price of $97.20, suggesting a potential upside of 33.80%. Given Cooper Companies' stronger consensus rating and higher possible upside, analysts plainly believe Cooper Companies is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
0 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.36
Cooper Companies
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73

In the previous week, Becton, Dickinson and Company had 11 more articles in the media than Cooper Companies. MarketBeat recorded 30 mentions for Becton, Dickinson and Company and 19 mentions for Cooper Companies. Becton, Dickinson and Company's average media sentiment score of 0.86 beat Cooper Companies' score of 0.85 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
13 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
10 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

Becton, Dickinson and Company and Cooper Companies tied by winning 8 of the 16 factors compared between the two stocks.

Get Becton, Dickinson and Company News Delivered to You Automatically

Sign up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BDX vs. The Competition

MetricBecton, Dickinson and CompanyMED/DENTAL IndustryMedical SectorNYSE Exchange
Market Cap$51.17B$15.50B$5.54B$20.76B
Dividend Yield2.33%1.46%4.25%3.68%
P/E Ratio34.0718.3428.2427.48
Price / Sales2.532.29426.8571.44
Price / Cash8.4416.8035.5321.88
Price / Book1.993.778.264.65
Net Income$1.71B$430.42M$3.24B$995.22M
7 Day Performance0.54%-1.59%0.62%-0.80%
1 Month Performance4.89%4.42%8.07%5.31%
1 Year Performance-23.82%15.19%27.96%8.94%

Becton, Dickinson and Company Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BDX
Becton, Dickinson and Company
4.7655 of 5 stars
$179.02
+0.4%
$219.22
+22.5%
-22.7%$51.28B$20.18B34.1574,000Analyst Revision
COO
Cooper Companies
3.084 of 5 stars
$73.65
-1.5%
$99.70
+35.4%
-19.3%$14.73B$3.90B35.7516,000Analyst Forecast
HOLX
Hologic
4.7124 of 5 stars
$64.65
-1.6%
$78.75
+21.8%
-18.6%$14.41B$4.03B27.287,063Positive News
Analyst Forecast
HSIC
Henry Schein
4.2756 of 5 stars
$70.68
-3.7%
$78.36
+10.9%
+2.6%$8.60B$12.67B22.0925,000News Coverage
Analyst Downgrade
Analyst Revision
AMN
AMN Healthcare Services
4.2444 of 5 stars
$20.72
-2.1%
$32.08
+54.8%
-65.0%$793.27M$2.85B-4.792,968Analyst Revision
CAH
Cardinal Health
4.8698 of 5 stars
$161.70
+0.5%
$157.43
-2.6%
+68.8%$38.59B$222.29B25.2348,900Positive News
Analyst Forecast
DVA
DaVita
4.4235 of 5 stars
$143.43
+0.6%
$164.50
+14.7%
+1.8%$10.83B$12.82B14.2176,000Positive News
MCK
McKesson
4.5876 of 5 stars
$716.46
+1.0%
$706.83
-1.3%
+22.5%$89.64B$359.05B27.7445,000Positive News
Analyst Forecast
Insider Trade
TMO
Thermo Fisher Scientific
4.9918 of 5 stars
$425.44
-2.2%
$600.30
+41.1%
-25.0%$160.60B$42.90B24.95125,000Positive News
Upcoming Earnings
Dividend Announcement
ISRG
Intuitive Surgical
4.6457 of 5 stars
$516.47
+0.9%
$592.86
+14.8%
+17.0%$185.11B$8.35B75.7315,638Trending News
Upcoming Earnings
Analyst Forecast
Analyst Revision
BSX
Boston Scientific
4.6302 of 5 stars
$104.39
+1.1%
$116.09
+11.2%
+32.0%$154.43B$16.75B76.1953,000Trending News
Upcoming Earnings

Related Companies and Tools


This page (NYSE:BDX) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners